Viral hepatitis
ナビゲーションに移動
検索に移動
| Navigation Menu |
| General issues of Vaccine | |||||||
|---|---|---|---|---|---|---|---|
|
| General issues of Travel med. | ||||||||
|---|---|---|---|---|---|---|---|---|
|
| Immunology | |||||||
|---|---|---|---|---|---|---|---|
|
| Epi & Stats | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Virus | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| COVID-19 | |||||
|---|---|---|---|---|---|
|
| Bacteria | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Rickettsia | |||||
|---|---|---|---|---|---|
|
| Protozoa | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Fungi | |||||||
|---|---|---|---|---|---|---|---|
|
| Nematode (roundworm) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Trematode (fluke, distoma) | |||||||
|---|---|---|---|---|---|---|---|
|
| Cestode (tapeworm) | ||||||
|---|---|---|---|---|---|---|
|
| Medical Zoology | ||||||||
|---|---|---|---|---|---|---|---|---|
|
hepatitis virus
- viral hepatitis is 4th major infectious disease worldwide
- virus hepatitis is still increasing year by year
- >250 mil. people living with viral hepatitis
- hep B highly prevalent sub-Saharan children <5y/o
- virus hepatitis has added to one of SDGs in 2016
hep A
- food-borne, water-borne
- infection route in Japan
- mainly by raw oyster in HIV-negative
- mainly MSM in HIV-positive
hep E
- water-borne, contaminated meat-borne
- incompletely cooked deer meat, pig intestine or liver
- non-enveloped, positive-sense, single-stranded RNA virus
- endemic in East to Southeast Asia
- genotype 4 is strongly associated to fluminant hepatitis
- hep E vaccine has already established in China
hep B
- family Hepadonavirus
- transmission route
- vertical
- horizontal
- sexually transmitted
- sharing needles
epidemiology
- 240 mil. hep B carriers worldwide
- 0.5 mil. death per year
- highly infectious; 10 virus copies are enough to infection
genotypes
- genotypes B and C prevalent in Asia
- A in Europe
acute hep B
- genotype A is increasing in Japan
- 10% of genotype A carrier develope chronic carrier
- 6.3% of hep B carrier are co-infected by hep C